IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
32 hedge funds and large institutions have $24.8M invested in Impel Pharmaceuticals Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less capital invested
Capital invested by funds: $99.6M → $24.8M (-$74.9M)
Holders
32
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$80.3K | |
| 2 | +$42K | |
| 3 | +$41K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$20.2K |
| 5 |
JP Morgan Chase
New York
|
+$3.53K |
Top Sellers
| 1 | -$535K | |
| 2 | -$187K | |
| 3 | -$168K | |
| 4 |
Jane Street
New York
|
-$49.3K |
| 5 |
State Street
Boston,
Massachusetts
|
-$17.2K |